Log in

No account? Create an account
entries friends calendar profile ABMann.net Previous Previous Next Next
Got my pressure rising. - Portrait of a Young Man as The Artist — LiveJournal
Got my pressure rising.
Oh screw you, New York Times.

I'm reading an article on the potential "benefits" of nation-wide electronic medical records. I speaks of effects withing the pharmacy market and how Kaiser Permanent is disrupting it.

    Still, the potential for market-disrupting cost savings is illustrated by what Kaiser and the V.A. have done in their drug management programs with statins, cholesterol-lowering drugs. Statins are the largest prescription drug category in the United States, with sales of $16 billion last year, according to IMS Health, a research group; Lipitor ($8.4 billion), from Pfizer, and Zocor ($4.4 billion), from Merck, took 80 percent of the market.

    In recent years, Kaiser and the V.A. have been using generic lovastatin for many of their patients taking statins, saving millions of dollars.At Kaiser, for example, its research pharmacists and cardiologists had been looking at closely at using the generic even before Merck’s Mevacor, the brand name for lovastatin, lost its patent protection in2001. Kaiser’s research on safety and effectiveness concluded that lovastatin could generally be used as an alternative.

I'm impressed at how this patient benefiting research is highlighted as a bad thing. It goes on to say that Liptor and Zocor are more potent versions of Lovastatin. So obviously they're better, right? At least it says the research is a good thing. i just can't help but feel like NYT is more interested in the pharm companies in this article.

Is brainwashing from pharm companies tis prevalent? Just because a drug is strong means it is better? Lowering patient costs for healthcare is good. Maybe reducing Lipitor's market share will actually spur Pfizer to research some new and useful drugs.

Current Mood: annoyed annoyed

2 comments or Leave a comment
zesty_pinto From: zesty_pinto Date: August 25th, 2006 06:14 pm (UTC) (Link)
Not to disagree with you, but most medications have a certain threshold before they stop becoming medication and start becoming poison.

And now I reread your entry and realized how off-topic it was.

Come on, bunnyman: if they can wine and dine doctors to recommend a drug that the practitioners have little to no knowledge on, then of course they can lobby. They might become the next big barons of industry.
aetrix9 From: aetrix9 Date: August 25th, 2006 06:30 pm (UTC) (Link)
I think "nonpartisan" support should now be equated to "Shotgun Lobbying" support.

Any time we can get Hillary AND Lott to agree on something, it obviously means the industry in question has bought off BOTH parties.

2 comments or Leave a comment